Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate, 3.0% QD + Dose 1 of glycopyrronium, 2.5% QD + Dose 2 of glycopyrronium, 3.75% QD
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hyperhidrosis
Conditions
Hyperhidrosis
Trial Timeline
Apr 1, 2014 → Jan 1, 2015
NCT ID
NCT02129660About Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate, 3.0% QD + Dose 1 of glycopyrronium, 2.5% QD + Dose 2 of glycopyrronium, 3.75% QD
Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate, 3.0% QD + Dose 1 of glycopyrronium, 2.5% QD + Dose 2 of glycopyrronium, 3.75% QD is a phase 2 stage product being developed by Journey Medical for Hyperhidrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02129660. Target conditions include Hyperhidrosis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02129660 | Phase 2 | Completed |
Competing Products
14 competing products in Hyperhidrosis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Umeclidinium + Vehicle | GSK plc | Phase 2 | 51 |
| glycopyrronium Topical Wipes | Journey Medical | Phase 3 | 69 |
| Glycopyrronium Topical Wipes | Journey Medical | Phase 3 | 69 |
| glycopyrrolate, 1.0% + glycopyrrolate, 2.0% + glycopyrrolate, 3.0% + glycopyrrolate, 4.0% | Journey Medical | Phase 2 | 44 |
| glycopyrronium Topical Wipes | Journey Medical | Phase 3 | 69 |
| Glycopyrronium cloth, 2.4% + Vehicle | Journey Medical | Phase 2 | 44 |
| BBI-4000 gel, 5% + BBI-4000 gel, 10% + BBI-4000 gel, 15% + Vehicle (Placebo) | Botanix Pharmaceuticals | Phase 2 | 44 |
| BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + Vehicle | Botanix Pharmaceuticals | Phase 2 | 44 |
| BBI-4000, 15% | Botanix Pharmaceuticals | Phase 2 | 44 |
| Sofpironium Bromide, 15% + Vehicle | Botanix Pharmaceuticals | Phase 3 | 69 |
| BBI-4000 | Botanix Pharmaceuticals | Phase 1 | 25 |
| Sofpironium Bromide Gel, 15% + Vehicle | Botanix Pharmaceuticals | Phase 3 | 69 |
| Sofpironium Bromide Gel, 5% + Sofpironium Bromide Gel, 15% | Botanix Pharmaceuticals | Phase 3 | 69 |
| Sofpironium Bromide Gel, 15% | Botanix Pharmaceuticals | Phase 2 | 44 |